Clinicopathological analysis of two pedigrees with Li-Fraumeni syndrome and literature review

To investigate the clinicopathological and molecular genetic characteristics of Li‑Fraumeni syndrome (LFS). Two patients from LFS pedigrees were analyzed retrospectively using clinicopathological data and genetic sequencing, along with a literature review. Case 1 was a 32‑year‑old female who carried a TP53 truncating mutation in the germline (c.​869del, p.​R290Pfs*55). Between the ages of 15 to 32 years, she manifested seven unique tumors: conventional osteosarcoma of the left radius, osteoblastic osteosarcoma of the right tibia, renal epithelioid angiomyolipoma, bilateral breast cancer, lung adenocarcinoma, adrenocortical carcinoma, and a benign angiomyofibroblastoma (AMF) located in the abdominal wall. Among these, six were identified as malignant or borderline lesions consistent with the classic LFS tumor spectrum, whereas the AMF contained the identical germline TP53 mutation and has not been previously described in LFS before. Case 2 was a 2-year-old boy with a germline missense in the TP53 mutation (c.​733 G > A, p.​G245S). At the age of 2, he was diagnosed with adrenocortical carcinoma with ATRX loss, a condition which was synchronous with his atypical choroid plexus papilloma of the lateral ventricle, a combination hitherto undocumented in relation to LFS. At the age of 9, he experienced a recurrence of adrenocortical carcinoma accompanied by liver metastases. The TP53 variants were validated as pathogenic. The aim of this study was to describe the occurrence of benign AMF (ICD-O: 8826/0) and atypical choroid plexus papilloma (ICD-O: 9390/1) in LFS cases, thereby extending the clinicopathological spectrum of LFS‑associated neoplasms.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Research and Clinical Oncology
Published
2026-11-17
DOI
https://doi.org/10.1007/s00432-026-06667-7
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinicopathological analysis of two pedigrees with Li-Fraumeni syndrome and literature review

胡小木, Lu He, Xue Zhang, Fanqing Meng et al.
Journal of Cancer Research and Clinical Oncology
Cancer-related Molecular Pathways
article

Clinicopathological analysis of two pedigrees with Li-Fraumeni syndrome and literature review

胡小木, Lu He, Xue Zhang, Fanqing Meng, Fengnan Niu, Qi Sun, Jialu Su, Xiaojia Liu
article en

Abstract

To investigate the clinicopathological and molecular genetic characteristics of Li‑Fraumeni syndrome (LFS). Two patients from LFS pedigrees were analyzed retrospectively using clinicopathological data and genetic sequencing, along with a literature review. Case 1 was a 32‑year‑old female who carried a TP53 truncating mutation in the germline (c.​869del, p.​R290Pfs*55). Between the ages of 15 to 32 years, she manifested seven unique tumors: conventional osteosarcoma of the left radius, osteoblastic osteosarcoma of the right tibia, renal epithelioid angiomyolipoma, bilateral breast cancer, lung adenocarcinoma, adrenocortical carcinoma, and a benign angiomyofibroblastoma (AMF) located in the abdominal wall. Among these, six were identified as malignant or borderline lesions consistent with the classic LFS tumor spectrum, whereas the AMF contained the identical germline TP53 mutation and has not been previously described in LFS before. Case 2 was a 2-year-old boy with a germline missense in the TP53 mutation (c.​733 G > A, p.​G245S). At the age of 2, he was diagnosed with adrenocortical carcinoma with ATRX loss, a condition which was synchronous with his atypical choroid plexus papilloma of the lateral ventricle, a combination hitherto undocumented in relation to LFS. At the age of 9, he experienced a recurrence of adrenocortical carcinoma accompanied by liver metastases. The TP53 variants were validated as pathogenic. The aim of this study was to describe the occurrence of benign AMF (ICD-O: 8826/0) and atypical choroid plexus papilloma (ICD-O: 9390/1) in LFS cases, thereby extending the clinicopathological spectrum of LFS‑associated neoplasms.

Journal of Cancer Research and Clinical Oncology
Fudan University (CN), Nanjing Drum Tower Hospital (CN), Huashan Hospital (CN)
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon